In the current study, Raman spectroscopy is employed for the identification of the biochemical changes taking place during the development of Hepatitis C. The Raman spectral data acquired from the human blood plasma samples of infected and healthy individuals is analysed by Principal Components Analysis and the Raman spectral markers of the Hepatitis C Virus (HCV) infection are identified. Spectral changes include those associated with nucleic acidsat720 cm -1 , 1077 cm -1 1678 (C=O stretching mode of dGTP of RNA), 1778 cm -1 (RNA), with proteins at 1641 cm -1 (amide-I), 1721 cm -1 (C=C stretching of proteins) and lipids at 1738 cm -1 (C=O of ester group in lipids). These differences in Raman spectral features of blood plasma samples of the patients and healthy volunteers can be associated with the development of the biochemical changes during HCV infection.
Introduction:
Hepatitis C is caused by the infection of a virus and almost 3% of the world and 4.8 % Pakistani population is affected by this disease (Shepard, Finelli et al. 2005; Lavanchy 2009; Ford, Kirby et al. 2012) . Currently available screening techniques, like Enzyme Linked Immunosorbent Assay (ELISA), involve the detection of the antibodies and pathogens in the blood of the patients infected by Hepatitis C virus (HCV) (Kesli, Polat et al. 2011) . Although, ELISA is very commonly employed, observation of the false positive and false negative results indicates difficulties in blood screening (Gretch 1997; Martin, Fabrizi et al. 1998; Schiff, de Medina et al. 1998 ).
Polymerase Chain Reaction (PCR) is currently considered as the gold standard technique for the direct detection of the HCV RNA, the most reliable disease marker, in blood serum or plasma (Raeymaekers 1993; Pawlotsky 2003) .To achieve accurate results from this method, the reagents and the instrumentation employed must be of high quality and sensitivity, respectively. In this regard, it is important to mention that PCR based methods are considered more reliable than ELISA based methods (Enomoto, Nishiguchi et al. 2001; Swellam, Mahmoud et al. 2011) , but the former technique is time consuming, less commonly available, laborious and expensive. This demands the development of more reliable, rapid, biochemical label free and automated diagnosis method which may be helpful for effective disease management.
Raman spectroscopy has been used for determining the biochemical changes in the biomacromolecules of cells and tissues, including lipids, proteins and DNA, simultaneously (Nawaz, Bonnier et al. 2010; Nawaz, Bonnier et al. 2011; Nawaz, Garcia et al. 2013) . Moreover, the technique has been employed for the analysis of the body fluids, like blood plasma/serum and urine, for the diagnosis of the diseases (Neugebauer, Trenkmann et al. 2014; Pachaiappan, Prakasarao et al. 2017; Pappu, Prakasarao et al. 2017) . The potential of Raman spectroscopy for the diagnosis of diseases which are caused by viral infections, such as dengue (Saleem, Bilal et al. 2013) and HPV (Ostrowska, Malkin et al. 2010; Ostrowska, Garcia et al. 2011 )has also been demonstrated.
Although the diagnosis of HCV infection in blood serum/plasma samples from infected patients by employing Raman spectroscopy has been reported, these studies used Principal Component Analysis (PCA) for the comparison of normal versus HCV positive samples (Saade, Pacheco et al. 2008 ) and a Partial Least Squares Regression (PLSR) model for the prediction of the viral load (Nawaz, Rashid et al. 2017) . In the present study, serologically characterised HCV positive blood plasma samples are divided into three different groups, for the purpose of comparison, namely low, medium and high viral load samples, and their Raman spectral data is compared with that of control/healthy samples by using PCA of these three degrees of infection of disease.
The analysis identifies specific spectral markers which may be associated with the presence, as well as degree of infection.
Materials and methods

Sample preparation
Blood plasma samples from 10 healthy/control and 11 Hepatitis C patients with different viral load values, as described in Table 1 , were collected from Allied Hospital, Faisalabad, Pakistan.
These patients were diagnosed as infected with HCV by the Polymerase Chain Reaction (PCR) technique, and classified into three groups on the basis of viral load values, currently a gold standard for the diagnosis of Hepatitis, which quantified the HCV loads in the patient samples.
Raman spectral acquisition
A 20 μl drop of each plasma sample was placed on an aluminium slide at room temperature and Raman spectra were acquired before the plasma sample had dried. The process of placing the 20μl drop on the aluminium slide was repeated 3 times by employing a clean aluminium slide each time for acquiring 20-25 spectra in total from each sample.
Raman spectral acquisition from all of the 10 healthy/control and 11 HCV infected blood plasma samples was performed using a Raman spectrometer (Peak Seeker Pro-785; Agiltron, USA). The
Peak Seeker Pro-785 utilizes a 785nm diode laser as the excitation source, delivering a laser power of ~60 mW at the sample. The laser was delivered to the sample through a 10× objective.
The acquisition of the Raman spectra for all the samples was executed from 600 to 1800 cm -1 and 20-25 Raman spectra per sample were acquired with an acquisition time of 30 seconds.
Data pre-processing
All data processing of the Raman spectra was performed using MatLab 7.8 and established protocols (Nawaz, Bonnier et al. 2010) . Data pre-processing included baseline correction, smoothing, vector normalisation, and substrate removal. All spectra, including substrate backgrounds, were vector normalised and smoothed using a Savitzky-Golay smoothing method (order 3, 17 point window). A rubber band correction for baseline removal for all the spectra was carried out and the substrate spectra were subtracted from each spectrum.
Data analysis
The Raman spectral features were analysed by comparing the mean Raman spectra of HCV infected blood plasma samples with healthy ones. The Raman peak assignments were taken from the literature, as detailed in Table 2 . PCA was used to differentiate groups of the spectral data To highlight the changes in the mean Raman spectra of HCV positive samples, he peak assignments have been labelled in Figures 1 (b-c) with; red boxes for prominent and striking differences in different viral load values, rectangles for intensity changes and vertical lines for other differences. Table 1 .(Vertical lines with red box are for striking differences ,without red box are showing intensity changes and doted box for bands and pattern change).
In Figure 2 , mean difference spectra, healthy minus HCV positive blood plasma samples, of different viral load values which, for the purpose of comparison (Table-1) , are divided into three classes including low (a), medium (b) and high (c), are shown. In the mean difference spectra, the differences in Raman spectral features associated with 3 different ranges of infection levels of HCV have been observed, and labeled. The difference spectra confirm the observations of Table- 1. Spectra are off-set for clarity. 
Conclusions
In order to identify the biochemical changes occurring during the process of Hepatitis C development, Raman spectroscopy along with Principal Component analysis is employed.
Raman spectral features as indicated by Principal Component analysis are hence established which can be associated with the human blood plasma samples of the infected and healthy individuals. Among others, the Raman spectral features which are observed only for the HCV positive samples include 720 cm -1 (adenine), 1077 cm -1 (PO2 stretching of RNA), 1678 C=O stretching mode of dGTP of RNA, 1778 cm -1 (RNA), 1641 (amide-I), 1721 cm -1 (C=C stretching of proteins)and 1738 cm -1 (C=O of ester group in lipids). These differences in Raman spectral features of blood plasma samples of the patients and healthy volunteers can be associated with the development of the biochemical changes during HCV infection.
